<DOC>
	<DOCNO>NCT00893828</DOCNO>
	<brief_summary>The PAPIRUS III study continue follow patient initially enrol PAPIRUS II . Pressure read investigational device continue collect correlated physiological change activity daily live protocol define test .</brief_summary>
	<brief_title>Monitoring Pulmonary Artery Pressure Implantable Device Responding Ultrasonic Signal ( PAPIRUS III )</brief_title>
	<detailed_description>This small clinical trial determine feasibility device &amp; test prototype device , primary outcome measure relate feasibility health outcome .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patient enrol PAPIRUS II Study RemonCHF pressure sensor implanted Patient willing able provide inform consent , participate Safety Followup Program and/or require test associate clinical investigation ( Core Study Program ) approve clinical investigational center interval define Clinical Investigational Plan . Patient enrol PAPIRUS II implant RemonCHF Pressure Sensor Patients currently enrol another investigational study registry would directly interfere current study ( exception PAPIRUS II Study ) . Each instance would bring sponsor determine eligibility . Age &lt; 18 year Women childbearing potential , might , pregnant time study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>